Figure - uploaded by Mikhail Fedyanin
Content may be subject to copyright.
Download
View publication
Factors affecting progression-free survival (multivariate analysis)

Factors affecting progression-free survival (multivariate analysis)

Source publication
Patients characteristics, n = 257
Factors affecting progression-free survival (multivariate analysis)
Progression-free survival in different prognostic groups
Factors affecting progression-free survival without considering...
Patient characteristics at the moment of aflibercept therapy initiation...
Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer
Article
Full-text available
  • Jun 2019
Objective: to identify factors associated with efficacy of an aflibercept-chemotherapy combination in patients with metastatic colon cancer.Materials and methods. This retrospective multicenter study was conducted in 20 clinics from 15 regions of the Russian Federation. The main efficacy outcome was progression-free survival (PFS). We performed uni...
Cite
Download full-text

Similar publications

Kaplan–Meier survival curves according to FHC. (a) Progression-free...
Kaplan–Meier survival curves according to MN. (a) Progression-free...
Activity data for overall population and subgroups.
Univariate and multivariate analysis for incidence of irAEs of any grade.
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
Article
Full-text available
  • Jan 2020
Background: We investigate the role of family history of cancer (FHC) and diagnosis of metachronous and/or synchronous multiple neoplasms (MN), during anti-PD-1/PD-L1 immunotherapy. Design: This was a multicenter retrospective study of advanced cancer patients treated with anti-PD-1/PD-L1 immunotherapy. FHC was collected in lineal and collateral li...
View